EXTH-26. PRMT5 AS A DRUGGABLE TARGET FOR GLIOBLASTOMA THERAPY

BACKGROUND: Glioblastoma (GBM) is the most common adult malignant brain tumor. In spite of standard multi modal therapy consisting of surgical resection followed by radiation and concurrent chemotherapy prognosis remains poor. As complexity of tumor heterogeneity is being increasingly recognized as...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Banasavadi-Siddegowda, Yeshavanth Kumar, Welker, Alessandra M, Imitola, Jaime, Li, Chenglong, Zhang, Jianying, Beattie, Christine E, Baiocchi, Robert, Kaur, Balveen
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2017
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692644/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.320
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados